Year-end Sale % OFF 
Abstract
Cancer disease results from mutations leading to apoptosis failure and immune system dysfunction. Because one in two people in developed counties will be diagnosed with cancer in their lifetimes, cancer and metastasis prevention should be ahead of therapies.The immune system in cancer patients is compromised and can be fixed with a reboot. The major oncofetal protein –alpha-feto protein –can deliver toxins instead of nutrients to the immune suppressor cells and kill them. The death of myeloid suppressor cells unleashes the immune attack on cancer cells, cancer stem cells, and metastases. Injectable and oral formulations of alpha-feto protein with toxins provide an opportunity to prevent and treat the disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
